May 26, 2017
Recommended Topic Related To:


"Nonsteroidal anti-inflammatory drug (NSAID) use during acute respiratory infection (ARI) increases the risk for acute myocardial infarction (AMI) 3.4-fold if taken by mouth and 7.2-fold with parenteral dosing compared with baseline risk without N"...




Risk Of Hemorrhage Including Spinal/Epidural Hematoma

If patients have had neuraxial anesthesia or spinal puncture, and particularly, if they are taking concomitant NSAIDs, platelet inhibitors, or other anticoagulants, inform the patients to watch for signs and symptoms of spinal or epidural hematoma, such as tingling, numbness (especially in the lower limbs) and muscular weakness. If any of these symptoms occur the patient should contact his or her physician immediately.

Additionally, the use of aspirin and other NSAIDs may enhance the risk of hemorrhage. Discontinue their use prior to dalteparin therapy whenever possible; if co-administration is essential, the patient’s clinical and laboratory status should be closely monitored [see DRUG INTERACTIONS].

Inform Patients

  • of the instructions for injecting FRAGMIN if their therapy is to continue after discharge from the hospitals.
  • it may take them longer than usual to stop bleeding.
  • they may bruise and/or bleed more easily when they are treated with FRAGMIN.
  • they should report any unusual bleeding, bruising, or signs of thrombocytopenia (such as a rash of dark red spots under the skin) to their physician [see WARNINGS AND PRECAUTIONS].
  • to tell their physicians and dentists they are taking FRAGMIN and/or any other product known to affect bleeding before any surgery is scheduled and before any new drug is taken [see WARNINGS AND PRECAUTIONS].
  • to tell their physicians and dentists of all medications they are taking, including those obtained without a prescription, such as aspirin or other NSAIDs [see DRUG INTERACTIONS].
  • Risks are associated with benzyl alcohol in neonates, infants, and pregnant women [see WARNINGS AND PRECAUTIONS and Use In Specific Populations].

FRAGMIN is a registered trademark of Pfizer Health AB.

Last reviewed on RxList: 5/25/2017
This monograph has been modified to include the generic and brand name in many instances.

Fragmin - User Reviews

Fragmin User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Fragmin sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Heart Health

Get the latest treatment options.

Atrial Fibrillation Quiz